Medical devices: standardised post-market surveillance report format
Information and recommendations for manufacturers on the preparation and presentation of a post-market surveillance report (PMSR).
Latest change: First published.
AI Summary
The Medicines and Healthcare products Regulatory Agency (MHRA) provides this guidance to assist medical device manufacturers in the preparation and submission of Post-Market Surveillance Reports (PMSR). This document establishes a regulatory framework for monitoring the safety and performance of medical devices once they are available on the UK market. Unlike an inspection report or warning letter, this guidance does not target a specific company, nor does it list inspection dates or specific violations; rather, it sets forth standardized expectations for industry-wide compliance. The guidance emphasizes a flexible approach to reporting, stating that manufacturers are only required to include data sections relevant to their specific products. Furthermore, the MHRA allows for data to be presented in various formats, provided the information effectively communicates the surveillance findings. Required actions for manufacturers include aligning their internal reporting processes with these guidelines to ensure that all post-market data is collected and analyzed systematically. By following these instructions, companies can ensure they meet the necessary regulatory obligations for ongoing safety monitoring, which is essential for maintaining product certification and protecting public health. This document serves as a critical resource for manufacturers to understand the depth and breadth of information required for robust post-market oversight.
The full document, source attachments, and change history are available on KeyPedia. Sign in to view.